Cargando…

COVID-19-associated fungal infections

Coronavirus disease 2019 (COVID-19)-associated invasive fungal infections are an important complication in a substantial number of critically ill, hospitalized patients with COVID-19. Three groups of fungal pathogens cause co-infections in COVID-19: Aspergillus, Mucorales and Candida species, includ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hoenigl, Martin, Seidel, Danila, Sprute, Rosanne, Cunha, Cristina, Oliverio, Matteo, Goldman, Gustavo H., Ibrahim, Ashraf S., Carvalho, Agostinho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9362108/ https://www.ncbi.nlm.nih.gov/pubmed/35918423 http://dx.doi.org/10.1038/s41564-022-01172-2

Ejemplares similares

EHA Endorsement of the Global Guideline for the Diagnosis and Management of Rare Mold Infection: An Initiative of the European Confederation of Medical Mycology in Cooperation With International Society for Human and Animal Mycology and American Society for Microbiology
por: Sprute, Rosanne, et al.
Publicado: (2021)

Social determinants of health as drivers of fungal disease
por: Jenks, Jeffrey D., et al.
Publicado: (2023)

P4 COVID19-associated fungal infections
por: Hoenigl, Martin
Publicado: (2022)

Editorial: An Omics Perspective on Fungal Infection: Toward Next-Generation Diagnosis and Therapy
por: Carvalho, Agostinho, et al.
Publicado: (2017)

Fungal Infections Complicating COVID-19: With the Rain Comes the Spores
por: Talento, Alida Fe, et al.
Publicado: (2020)

EQUAL CPA Score 2022: a tool to measure guideline adherence for chronic pulmonary aspergillosis
por: Sprute, Rosanne, et al.
Publicado: (2022)

DAMP signaling in fungal infections and diseases
por: Cunha, Cristina, et al.
Publicado: (2012)

All You Need To Know and More about the Diagnosis and Management of Rare Yeast Infections
por: Sprute, Rosanne, et al.
Publicado: (2021)

604. IL-17C as an early diagnostic biomarker for invasive fungal infection or just a marker of any infection in at-risk haematology patients
por: Aerts, Robina, et al.
Publicado: (2023)

Point of Care Testing for the Diagnosis of Fungal Infections: Are We There Yet?
por: Prattes, Juergen, et al.
Publicado: (2016)

Results from a national survey on COVID‐19‐associated mucormycosis in Germany: 13 patients from six tertiary hospitals
por: Seidel, Danila, et al.
Publicado: (2021)

COVID-19-Associated Candidiasis (CAC): An Underestimated Complication in the Absence of Immunological Predispositions?
por: Arastehfar, Amir, et al.
Publicado: (2020)

The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries
por: Hoenigl, Martin, et al.
Publicado: (2022)

Invasive Fungal Disease Complicating Coronavirus Disease 2019: When It Rains, It Spores
por: Hoenigl, Martin
Publicado: (2020)

EQUAL Trichosporon Score 2022: an ECMM score to measure QUALity of the clinical management of invasive Trichosporon infections
por: Sprute, Rosanne, et al.
Publicado: (2022)

Comment on: Nephrotoxicity of continuous amphotericin B in critically ill patients with abdominal sepsis: a retrospective analysis with propensity score matching
por: Grothe, Jan, et al.
Publicado: (2022)

Correspondence to: hemophagocytic lymphohistiocytosis after SARS-CoV-2 vaccination
por: Sprute, Rosanne, et al.
Publicado: (2022)

Race and ethnicity: Risk factors for fungal infections?
por: Jenks, Jeffrey D., et al.
Publicado: (2023)

The Cell Biology of the Trichosporon-Host Interaction
por: Duarte-Oliveira, Cláudio, et al.
Publicado: (2017)

The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin
por: Hoenigl, Martin, et al.
Publicado: (2021)

Characterization and outcome of invasive infections due to Paecilomyces variotii: analysis of patients from the FungiScope(®) registry and literature reports
por: Sprute, Rosanne, et al.
Publicado: (2020)

New Opportunities for Modern Fungal Biology
por: Goldman, Gustavo Henrique
Publicado: (2020)

COVID-19 Associated Pulmonary Aspergillosis (CAPA)—From Immunology to Treatment
por: Arastehfar, Amir, et al.
Publicado: (2020)

Reason and reality—identifying barriers to patient enrolment for clinical trials in invasive candidiasis
por: Sprute, Rosanne, et al.
Publicado: (2022)

Primary prophylaxis of invasive fungal diseases in patients with haematological malignancies: 2022 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)
por: Stemler, Jannik, et al.
Publicado: (2023)

617. Laboratory capacities to diagnose and treat Invasive Fungal Infections in Europe: results from an ECMM survey
por: Salmanton-Garcia, Jon, et al.
Publicado: (2023)

Opportunistic Fungal Infection Associated With COVID-19
por: Cafardi, John, et al.
Publicado: (2021)

Invasive Fungal Infections Associated with COVID-19
por: Hlaing, Kyaw M., et al.
Publicado: (2023)

COVID-19–Associated Pulmonary Aspergillosis, March–August 2020
por: Salmanton-García, Jon, et al.
Publicado: (2021)

Delayed Cutaneous Hypersensitivity Reaction to Vaxzevria (ChAdOx1-S) Vaccine against SARS-CoV-2
por: Sprute, Rosanne, et al.
Publicado: (2021)

The silent flucytosine shortage in Europe – not a distant problem
por: Sprute, Rosanne, et al.
Publicado: (2023)

2046. FungiScope™: News on the Global Emerging Fungal Infection Registry
por: Seidel, Danila, et al.
Publicado: (2018)

COVID-19 and Plethora of Fungal Infections
por: Kundu, Reetu, et al.
Publicado: (2022)

Diagnosis of Breakthrough Fungal Infections in the Clinical Mycology Laboratory: An ECMM Consensus Statement
por: Jenks, Jeffrey D., et al.
Publicado: (2020)

Overview of COVID-19-Associated Invasive Fungal Infection
por: Shishido, Akira A., et al.
Publicado: (2022)

An overview of opportunistic fungal infections associated with COVID-19
por: Kangabam, Navidita, et al.
Publicado: (2023)

Flotillin-Dependent Membrane Microdomains Are Required for Functional Phagolysosomes against Fungal Infections
por: Schmidt, Franziska, et al.
Publicado: (2020)

COVID-19–associated mucormycosis: a systematic review and meta-analysis of 958 cases
por: Özbek, Laşin, et al.
Publicado: (2023)

COVID-19 associated pulmonary aspergillosis: regional variation in incidence and diagnostic challenges
por: Prattes, Juergen, et al.
Publicado: (2021)

Invasive infections with Purpureocillium lilacinum: clinical characteristics and outcome of 101 cases from FungiScope(®) and the literature
por: Sprute, Rosanne, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_q7tjt9erdcaneq9ns3c38rbjuh